Bridgebio Pharma Correlations

BBIO
 Stock
  

USD 10.60  0.19  1.76%   

The correlation of Bridgebio Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bridgebio Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bridgebio Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Continue to Trending Equities.
  
Refresh
The ability to find closely correlated positions to Bridgebio Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bridgebio Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bridgebio Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bridgebio Pharma to buy it.

Moving together with Bridgebio Pharma

0.86BLIBerkeley LightsPairCorr
0.78MBIOMustang BioPairCorr
0.76BTXBrooklyn ImmunotherapeutiPairCorr
0.88MBRXMoleculin BiotechPairCorr
0.9BCABBioatlaPairCorr
0.67BCDABiocardiaPairCorr
0.69BCLIBrainstorm CellPairCorr
0.74BCRXBiocryst PharmaPairCorr
0.83MCRBSeres TherapeuticsPairCorr
0.85BCTXBriaCell Therapeutics Fiscal Year End 27th of October 2022 PairCorr
0.75BCYCBicycle Therapeutics PlcPairCorr
0.85MDGLMadrigal PharmaceuticalsPairCorr
0.78MDNAMedicenna TherapeuticsPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
FUBER
UBERMSFT
FMSFT
CRMMSFT
JPMA
JPMF
  
High negative correlations   

Bridgebio Pharma Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Bridgebio Pharma stock performing well and Bridgebio Pharma company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Bridgebio Pharma's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 2.75  0.17  0.07  0.12  3.48  0.06 (2.91)  5.66 (5.40)  36.79 
MSFT 1.93  0.03  0.00 (0.18)  0.00 (0.0227)  0.00  2.97 (4.24)  9.36 
UBER 3.44 (0.30)  0.00 (0.36)  0.00 (0.11)  0.00  6.32 (7.19)  18.56 
F 2.37 (0.30)  0.00 (0.39)  0.00 (0.14)  0.00  3.68 (5.54)  16.83 
T 1.32  0.38  0.28  0.38  1.36  0.25 (1.53)  2.99 (2.47)  12.17 
A 1.97  0.08  0.00 (0.13)  0.00  0.0176  0.00  3.19 (3.50)  9.78 
CRM 2.65  0.05  0.00 (0.17)  0.00 (0.0276)  0.00  6.33 (5.28)  16.84 
JPM 1.47 (0.11)  0.00 (0.30)  0.00 (0.06)  0.00  2.98 (3.00)  10.78 
MRK 1.07  0.29  0.33  0.38  0.99  0.27 (1.23)  2.16 (1.65)  7.61 
XOM 2.00  0.24  0.08  0.06  2.97  0.1 (1.71)  3.03 (3.96)  11.86 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bridgebio Pharma without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Directory Now

   

Bond Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Investing Bridgebio Pharma

You need to understand the risk of investing before taking a position in Bridgebio Pharma. The danger of trading Bridgebio Pharma is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bridgebio Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bridgebio Pharma. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bridgebio Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Bridgebio Pharma information on this page should be used as a complementary analysis to other Bridgebio Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Bridgebio Stock analysis

When running Bridgebio Pharma price analysis, check to measure Bridgebio Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bridgebio Pharma is operating at the current time. Most of Bridgebio Pharma's value examination focuses on studying past and present price action to predict the probability of Bridgebio Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bridgebio Pharma's price. Additionally, you may evaluate how the addition of Bridgebio Pharma to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Is Bridgebio Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bridgebio Pharma. If investors know Bridgebio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bridgebio Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.5 B
Quarterly Revenue Growth YOY
2.67
Return On Assets
-0.37
Return On Equity
-17.9
The market value of Bridgebio Pharma is measured differently than its book value, which is the value of Bridgebio that is recorded on the company's balance sheet. Investors also form their own opinion of Bridgebio Pharma's value that differs from its market value or its book value, called intrinsic value, which is Bridgebio Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bridgebio Pharma's market value can be influenced by many factors that don't directly affect Bridgebio Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bridgebio Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Bridgebio Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bridgebio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.